![Andres McAllister](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 7 139 $ per 2026-08-31
Andres McAllister is currently Chief Medical Officer at BioInvent International AB since 2017.
Former positions include Director-Research & Development at Immune Design Corp., Non-Executive Director at Immunexpress Pty Ltd., Principal at Institut Pasteur, Chief Scientific Officer at Debiopharm International SA from 2004 to 2015, Principal at The University of California, San Francisco, and Principal at Centre d'Immunologie Pierre Fabre.
Education includes doctorates from Université Paris 1 Panthéon-Sorbonne and Universidad del Rosario.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-31 | 3 009 ( 0 % ) | 7 139 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Teknisk/Vetenskaplig/F&U Direktör | 2017-01-01 |
| Företag | Position | Slut |
|---|---|---|
Debiopharm International SA
 Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Teknisk/Vetenskaplig/F&U Direktör | 2015-09-01 |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Direktör/Styrelseledamot | - |
Centre d'Immunologie Pierre Fabre | Företagsledare/Principal | - |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Företagsledare/Principal | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Health Technology |
Universidad del Rosario
 Universidad del Rosario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre d'Immunologie Pierre Fabre |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
